单细胞分析揭示早期与晚期系统性硬化症皮肤在自身抗体亚组间的关键差异
对12例弥漫性皮肤型系统性硬化症(dcSSc)患者和3例健康对照的前臂皮肤活检行单细胞RNA测序,按病程(>5年或<5年)和自身抗体(ATA+或ARA+)分层分析。结果显示所有细胞及成纤维细胞亚簇可按疾病、分期和抗体清晰区分;早期ATA+dcSSc皮肤的TGFβ反应主要见于成纤维细胞和平滑肌细胞,而早期ARA+dcSSc皮肤中应答细胞为内皮细胞。作者认为这些差异强调在系统性硬化症管理和试验设计中应考虑自身抗体和疾病分期。
要点
- dcSSc皮肤单细胞转录组可按疾病、分期和自身抗体亚组清晰分离。
- 早期ATA+dcSSc皮肤的TGFβ反应主要见于成纤维细胞和平滑肌细胞。
- 早期ARA+dcSSc皮肤的TGFβ应答细胞为内皮细胞。
核心结论
- 研究识别出dcSSc两种主要自身抗体亚组(ARA+和ATA+)之间的细胞差异,作者认为这些差异强调在系统性硬化症管理和试验设计中考虑自身抗体和疾病分期的重要性。
研究设计与样本
- 对12例dcSSc患者和3例健康对照的4 mm皮肤活检样本行基于液滴的单细胞RNA测序(10× genomics)。
- 患者按病程(>5年或<5年)和自身抗体(ATA+或ARA+)进行特征描述。
- 分析全皮肤细胞亚群和成纤维细胞亚群在分期和ANA亚组间的差异,共分析15份前臂皮肤活检。
主要发现
- 所有细胞及成纤维细胞亚簇可按疾病、分期和抗体清晰分离。
- ATA+与ARA+患者的细胞簇基因表达谱存在差异。
- 细胞间相互作用提示早期与晚期疾病及自身抗体间存在不同相互作用。
- 早期ATA+dcSSc皮肤样本中TGFβ反应主要见于成纤维细胞和平滑肌细胞。
- 早期ARA+dcSSc患者皮肤样本中应答细胞为内皮细胞。
临床怎么用
- 作者认为这些差异强调在系统性硬化症管理和试验设计中考虑自身抗体和疾病分期的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The severity of skin involvement in diffuse cutaneous systemic sclerosis (dcSSc) depends on stage of disease and differs between anti-RNA-polymerase III (ARA) and anti-topoisomerase antibody (ATA) subsets. We have investigated cellular differences in well-characterised dcSSc patients compared with healthy controls (HCs). METHODS: We performed single-cell RNA sequencing on 4 mm skin biopsy samples from 12 patients with dcSSc and HCs (n=3) using droplet-based sequencing (10× genomics). Patients were well characterised by stage (>5 or <5 years disease duration) and autoantibody (ATA+ or ARA+). Analysis of whole skin cell subsets and fibroblast subpopulations across stage and ANA subgroup were used to interpret potential cellular differences anchored by these subgroups. RESULTS: Fifteen forearm skin biopsies were analysed. There was a clear separation of SSc samples, by disease, stage and antibody, for all cells and fibroblast subclusters. Further analysis revealed differing cell cluster gene expression profiles between ATA+ and ARA+ patients. Cell-to-cell interaction suggest differing interactions between early and late stages of disease and autoantibody. TGFβ response was mainly seen in fibroblasts and smooth muscle cells in early ATA+dcSSc skin samples, whereas in early ARA+dcSSc patient skin samples, the responding cells were endothelial, reflect broader differences between clinical phenotypes and distinct skin score trajectories across autoantibody subgroups of dcSSc. CONCLUSIONS: We have identified cellular differences between the two main autoantibody subsets in dcSSc (ARA+ and ATA+). These differences reinforce the importance of considering autoantibody and stage of disease in management and trial design in SSc.
引用
- Clark KEN, Xu S, Attah M, et al. Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups. Ann Rheum Dis. 2023. PMID: 37580109. doi:10.1136/ard-2023-224184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。